Sei Investments Co. Cuts Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Sei Investments Co. trimmed its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 19.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 408,777 shares of the company’s stock after selling 95,973 shares during the period. Sei Investments Co. owned approximately 0.16% of Ryan Specialty worth $26,227,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in RYAN. Sanctuary Advisors LLC raised its stake in Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock valued at $1,045,000 after buying an additional 188 shares during the last quarter. State of Alaska Department of Revenue raised its position in shares of Ryan Specialty by 1.6% in the 4th quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock worth $778,000 after purchasing an additional 190 shares during the last quarter. CIBC Asset Management Inc boosted its stake in Ryan Specialty by 5.6% in the 4th quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock worth $236,000 after purchasing an additional 196 shares in the last quarter. Loomis Sayles & Co. L P grew its position in Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after purchasing an additional 286 shares during the last quarter. Finally, Exchange Traded Concepts LLC increased its stake in Ryan Specialty by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock valued at $755,000 after purchasing an additional 295 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on RYAN shares. Keefe, Bruyette & Woods dropped their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research note on Friday, February 21st. UBS Group increased their target price on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Morgan Stanley assumed coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. Wells Fargo & Company increased their price objective on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research report on Friday, February 21st. Finally, Royal Bank of Canada decreased their target price on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $75.27.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 29,466 shares of the stock in a transaction on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the completion of the sale, the director now owns 45,409 shares in the company, valued at approximately $2,954,309.54. This represents a 39.35 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the business’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold 241,360 shares of company stock valued at $16,006,428 over the last quarter. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Price Performance

Shares of NYSE:RYAN opened at $71.49 on Thursday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market capitalization of $18.72 billion, a PE ratio of 103.61, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The firm’s 50 day moving average price is $68.49 and its 200-day moving average price is $68.15. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date was Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.67%. Ryan Specialty’s dividend payout ratio is presently 69.57%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.